ArticleJournal of clinical immunology2012

Brief treatment with iNKT cell ligand α-galactosylceramide confers a long-term protection against lupus.

Jun-Qi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.